| __timestamp | Arrowhead Pharmaceuticals, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 24419536 | 2999000 |
| Thursday, January 1, 2015 | 34718089 | 10393000 |
| Friday, January 1, 2016 | 40998209 | 15994000 |
| Sunday, January 1, 2017 | 32022880 | 26975000 |
| Monday, January 1, 2018 | 19110051 | 39509000 |
| Tuesday, January 1, 2019 | 26556257 | 48869000 |
| Wednesday, January 1, 2020 | 52275890 | 42510000 |
| Friday, January 1, 2021 | 80981000 | 46105000 |
| Saturday, January 1, 2022 | 124431000 | 50513000 |
| Sunday, January 1, 2023 | 90932000 | 51292000 |
| Monday, January 1, 2024 | 98761000 |
Data in motion
In the competitive landscape of biotechnology, effective cost management is crucial. Arrowhead Pharmaceuticals, Inc. and Wave Life Sciences Ltd. offer a compelling study in contrasts. Over the past decade, Arrowhead's Selling, General, and Administrative (SG&A) expenses have surged by over 300%, peaking in 2022. This reflects their aggressive expansion and investment in innovation. Meanwhile, Wave Life Sciences has maintained a steadier trajectory, with expenses increasing by approximately 70% since 2014, indicating a more conservative growth strategy.
Understanding these trends provides valuable insights into each company's strategic priorities and market positioning.
Selling, General, and Administrative Costs: Biogen Inc. vs Wave Life Sciences Ltd.
Selling, General, and Administrative Costs: BeiGene, Ltd. vs Arrowhead Pharmaceuticals, Inc.
Viatris Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Sarepta Therapeutics, Inc. vs Wave Life Sciences Ltd. Trends and Insights
Breaking Down SG&A Expenses: Corcept Therapeutics Incorporated vs Arrowhead Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Alkermes plc vs Wave Life Sciences Ltd.
SG&A Efficiency Analysis: Comparing Viking Therapeutics, Inc. and Wave Life Sciences Ltd.
Who Optimizes SG&A Costs Better? Amicus Therapeutics, Inc. or Wave Life Sciences Ltd.
Operational Costs Compared: SG&A Analysis of HUTCHMED (China) Limited and Arrowhead Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Arrowhead Pharmaceuticals, Inc. and MannKind Corporation
Who Optimizes SG&A Costs Better? Supernus Pharmaceuticals, Inc. or Wave Life Sciences Ltd.
Soleno Therapeutics, Inc. and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared